AU2014203364B2 - Stable digestive enzyme compositions - Google Patents
Stable digestive enzyme compositionsInfo
- Publication number
- AU2014203364B2 AU2014203364B2 AU2014203364A AU2014203364A AU2014203364B2 AU 2014203364 B2 AU2014203364 B2 AU 2014203364B2 AU 2014203364 A AU2014203364 A AU 2014203364A AU 2014203364 A AU2014203364 A AU 2014203364A AU 2014203364 B2 AU2014203364 B2 AU 2014203364B2
- Authority
- AU
- Australia
- Prior art keywords
- digestive enzyme
- compositions
- enzyme compositions
- less
- stable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 108091007734 digestive enzymes Proteins 0.000 title abstract 4
- 102000038379 digestive enzymes Human genes 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 4
- 230000000694 effects Effects 0.000 abstract 2
- XRHVZWWRFMCBAZ-UHFFFAOYSA-L Endothal-disodium Chemical compound [Na+].[Na+].C1CC2C(C([O-])=O)C(C(=O)[O-])C1O2 XRHVZWWRFMCBAZ-UHFFFAOYSA-L 0.000 abstract 1
- 108010067035 Pancrelipase Proteins 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000007812 deficiency Effects 0.000 abstract 1
- 239000002702 enteric coating Substances 0.000 abstract 1
- 238000009505 enteric coating Methods 0.000 abstract 1
- 229940045258 pancrelipase Drugs 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 238000012430 stability testing Methods 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02W—CLIMATE CHANGE MITIGATION TECHNOLOGIES RELATED TO WASTEWATER TREATMENT OR WASTE MANAGEMENT
- Y02W90/00—Enabling technologies or technologies with a potential or indirect contribution to greenhouse gas [GHG] emissions mitigation
- Y02W90/10—Bio-packaging, e.g. packing containers made from renewable resources or bio-plastics
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
STABLE DIGESTIVE ENZYME COMPOSITIONS Compositions disclosed herein, comprising at least one digestive enzyme (e.g., pancrelipase), are useful for treating or preventing disorders associated with digestive enzyme deficiencies. The compositions may comprise a plurality of coated particles, each of which is comprised of a core coated with an enteric coating comprising at least one enteric polymer and 4-10% of at least one alkalinizing agent, or have moisture contents of about 3% or less, water activities of about 0.6 or less, or exhibit a loss of activity of no more than about 15% after six months of accelerated stability testing.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2014203364A AU2014203364B2 (en) | 2007-02-20 | 2014-06-20 | Stable digestive enzyme compositions |
| AU2016204414A AU2016204414B2 (en) | 2007-02-20 | 2016-06-27 | Stable digestive enzyme compositions |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60/902,093 | 2007-02-20 | ||
| US60/902,092 | 2007-02-20 | ||
| US60/902,091 | 2007-02-20 | ||
| AU2012202620A AU2012202620B2 (en) | 2007-02-20 | 2012-05-03 | Stable digestive enzyme compositions |
| AU2014203364A AU2014203364B2 (en) | 2007-02-20 | 2014-06-20 | Stable digestive enzyme compositions |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2012202620A Division AU2012202620B2 (en) | 2007-02-20 | 2012-05-03 | Stable digestive enzyme compositions |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2016204414A Division AU2016204414B2 (en) | 2007-02-20 | 2016-06-27 | Stable digestive enzyme compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2014203364A1 AU2014203364A1 (en) | 2014-07-10 |
| AU2014203364B2 true AU2014203364B2 (en) | 2016-07-21 |
Family
ID=51243474
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2014203364A Ceased AU2014203364B2 (en) | 2007-02-20 | 2014-06-20 | Stable digestive enzyme compositions |
Country Status (1)
| Country | Link |
|---|---|
| AU (1) | AU2014203364B2 (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0576938A1 (en) * | 1992-06-22 | 1994-01-05 | Digestive Care Inc. | Composition of digestive enzymes and salts of bile acids and process for preparation thereof |
-
2014
- 2014-06-20 AU AU2014203364A patent/AU2014203364B2/en not_active Ceased
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0576938A1 (en) * | 1992-06-22 | 1994-01-05 | Digestive Care Inc. | Composition of digestive enzymes and salts of bile acids and process for preparation thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2014203364A1 (en) | 2014-07-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2008102264A3 (en) | Stable digestive enzyme compositions | |
| Ivanova et al. | Layer‐by‐layer coating of aminocellulose and quorum quenching acylase on silver nanoparticles synergistically eradicate bacteria and their biofilms | |
| Ervin et al. | Relationship between the gut microbiome and systemic chemotherapy | |
| EP3333258A3 (en) | Method for degrading or converting cellulosic material | |
| WO2004022031A3 (en) | Stable probiotic microsphere compositions and their methods of preparation | |
| EP2428572A3 (en) | Alkaliphilic Bacillus species alpha-amylase variants, compositions comprising alpha-amylase variants, and methods of use | |
| IL151150A0 (en) | Multiparticulate drug form comprising at least two differently coated pellet forms | |
| GB2407822A (en) | Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury | |
| BRPI0408165A (en) | processes to improve the activity of lignocellulose degradation enzymes | |
| WO2011163483A3 (en) | Polymers for biomaterials and therapeutics | |
| WO2000071493A3 (en) | INHIBITORS OF FACTOR Xa | |
| JP2011525500A5 (en) | ||
| MX346974B (en) | Small enzyme-containing granules. | |
| AU2001289457A1 (en) | Methods and compositions employing a novel stearoyl-coa desaturase-hscd5 | |
| EA200501700A1 (en) | APPLICATION OF EFFECTS OF GLUTAMINIL AND GLUTAMIC CYCLASE | |
| NZ592665A (en) | Controlled release methylphenidate compostions comprising at least two groups of particles, each with a methylphenidate core coated with a controlled release polymer coating, each group distinguished by the coating thickness | |
| WO2024033135A3 (en) | Amylase variants | |
| EP1839499A4 (en) | COMPOSITION COMPRISING A HIGHLY DISPERSIBLE CELLULOSE COMPLEX AND A POLYSACCHARIDE | |
| WO2010019914A3 (en) | Anti-arrhythmia agents, methods of their use, methods for their identification, and kits thereofre | |
| UY32896A (en) | COMPOSITIONS OF PANCREATIC ENZYMES AND METHODS TO TREAT PANCREATITIS AND PANCREATIC INSUFFICIENCY | |
| Wu et al. | The bioactive interface of titanium implant with both anti‐oxidative stress and immunomodulatory properties for enhancing osseointegration under diabetic condition | |
| WO2009074969A3 (en) | Spingosine-1-phosphate, analogues and antagonists for use as medicaments | |
| WO2006085335A3 (en) | Pharmaceutical composition of acid labile substances | |
| CO6150185A2 (en) | ANTI-COCAINE AND TREATMENT COMPOSITIONS | |
| AU2014203364B2 (en) | Stable digestive enzyme compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| PC | Assignment registered |
Owner name: ALLERGAN THERAPEUTICS LLC Free format text: FORMER OWNER(S): APTALIS PHARMA LIMITED |
|
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |